Cargando…
Optimising the treatment for uncomplicated acute appendicitis (OPTIMA trial): a protocol for a multicentre, randomised, double-blinded placebo-controlled study
INTRODUCTION: Emerging evidence has shown that an antibiotic first strategy is a viable treatment option for uncomplicated acute appendicitis (AA). Although there has recently been an interest and increase in the use of antibiotics as the primary strategy for treating uncomplicated AA, there is no c...
Autores principales: | Wu, Jie, Jiang, Haiyang, Li, Shikuan, Wu, Xiuwen, Wang, Peige, Sawyer, Robert, Ren, Jianan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062814/ https://www.ncbi.nlm.nih.gov/pubmed/35501082 http://dx.doi.org/10.1136/bmjopen-2021-057793 |
Ejemplares similares
-
A randomised placebo-controlled double-blind multicentre trial comparing
antibiotic therapy with placebo in the treatment of uncomplicated acute appendicitis:
APPAC III trial study protocol
por: Sippola, Suvi, et al.
Publicado: (2018) -
Optimising the antibiotic treatment of uncomplicated acute appendicitis: a protocol for a multicentre randomised clinical trial (APPAC II trial)
por: Haijanen, J., et al.
Publicado: (2018) -
Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): design of a multicentre, randomised, double-blind, placebo-controlled, parallel-group study
por: Rafique, Zubaid, et al.
Publicado: (2023) -
Relieving acute pain (RAP) study: a proof-of-concept protocol for a randomised, double-blind, placebo-controlled trial
por: Colloca, Luana, et al.
Publicado: (2019) -
Antibiotics versus placebo in adults with CT-confirmed uncomplicated acute appendicitis (APPAC III): randomized double-blind superiority trial
por: Salminen, Paulina, et al.
Publicado: (2022)